基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Samik Basu is a physician-scientist focused with experience in translational research, large and small biologics development, checkpoint blockade, tumor immunology, cellular immunotherapy, T cell immunology, autoimmunity, in vivo modelling, signal transduction, and gene therapy. He joined Cabaletta in December 2019 and was most recently Vice President of Preclinical Research and Translational Medicine before assuming his new role as Chief Scientific Officer. Prior to joining Cabaletta, Dr. Basu was Head of Translational Sciences (Medicine) at Adaptimmune Therapeutics, Plc, where he led research efforts focused on understanding the mechanisms of resistance and response to TCR based adoptive immunotherapies to inform next generation approaches and clinical strategies. Before that, Dr. Basu co-led preclinical development efforts for Keytruda (pembrolizumab) at Merck Research Laboratories. He is a physician-scientist with over 15 years of industry and academic experience in adoptive immunotherapy, translational research, autoimmunity, and tumor immunology with prior roles at the National Institutes of Health, Albert Einstein College of Medicine, and the University of Pennsylvania. Dr. Basu received his M.D. from Temple University and completed residency training in Clinical Pathology.
Research Interests
Papers共 32 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Binghao J. Peng,Andrea Alvarado, Hangameh Cassim, Soprina Guarneri, Steven Wong, Jonathan Willis, Julia SantaMaria, Ashley Martynchuk, Victoria Stratton,Darshil Patel, Chien-Chung Chen, Yan Li,
Molecular Therapy - Methods & Clinical Developmentpp.101267, (2024)
Binghao J Peng,Andrea Alvarado, Hangameh Cassim, Soprina Guarneri, Steven Wong, Jonathan Willis, Julia SantaMaria, Ashley Martynchuk, Victoria Stratton,Darshil Patel, Chien-Chung Chen, Yan Li,
Molecular therapy. Methods & clinical developmentno. 2 (2024): 101267-101267
Jenell R. Volkov,Daniel Nunez, Mallorie Fouch, Jason Stadanlick, Zachary J. Vorndran, Chris Schmitt, Claire M. Miller, Kate A. Richetti,Xiaolong Zhou,Michi Shinohara,Robert Micheletti, Emanuele Maverakis,
MOLECULAR THERAPYno. 4 (2023): 545-545
Cited0Views0Bibtex
0
0
Binghao J. Peng,Andrea Alvarado, Hangameh Cassim, Ebony Cottman-Thomas, Soprina Guarneri, Ashley Martynchuk, Erica Devitt, Ivan Martinez, Jimmy Perry, Victoria Stratton, Vicky Li, Jonathan Willis,
MOLECULAR THERAPYno. 4 (2023): 669-669
Molecular therapy. Methods & clinical development (2023): 101104-101104
MUSCLE & NERVEno. 4 (2022): 15-15
Cited0Views0Bibtex
0
0
S. Basu, J. Volkov,D. Nunez, M. Fouch, J. Stadanlick, G. Binder, D. Chang,K. Hoffman,D. Porter, M. Abedi,W. K. Weng,R. Micheletti,
Cited0Views0Bibtex
0
0
D. J. Chang,S. Basu,R. Micheletti,E. Maverakis,M. Marinkovich,D. L. Porter, M. Abedi, W. Weng, K. Hoffman, J. Volkov, D. Nunez,M. C. Milone,
Cited1Views0Bibtex
1
0
Jinmin Lee,Sangwook Oh,Samik Basu,Uri Herzberg,Silvio Manfredo-Vieira,Darshil Patel,Gwendolyn K. Binder,Michael C. Milone,Kevin C. O'Connor, Fabian D. Arditti, Rukiye Nazan-Eraslan,Rachel Fong,
Cited0Views0Bibtex
0
0
Load More
Author Statistics
#Papers: 27
#Citation: 1497
H-Index: 14
G-Index: 27
Sociability: 6
Diversity: 0
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn